|
1
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stracci F, Zorzi M and Grazzini G:
Colorectal cancer screening: Tests, strategies, and perspectives.
Front Public Health. 2:2102014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Puylaert JB, van der Zant FM and Rijke AM:
Sonography and the acute abdomen: Practical considerations. AJR Am
J Roentgenol. 168:179–186. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laméris W, van Randen A, Dijkgraaf MG,
Bossuyt PM, Stoker J and Boermeester MA: Optimization of diagnostic
imaging use in patients with acute abdominal pain (OPTIMA): Design
and rationale. BMC Emerg Med. 7:92007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dhillon S, Halligan S, Goh V, Matravers P,
Chambers A and Remedios D: The therapeutic impact of abdominal
ultrasound in patients with acute abdominal symptoms. Clin Radiol.
57:268–271. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Ultrasonography for
leukocytosis or elevated C-reactive protein.
Hepatogastroenterology. 58:1156–1158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomizawa M, Shinozaki F, Hasegawa R, Fugo
K, Shirai Y, Ichiki N, Sugiyama T, Yamamoto S, Sueishi M and
Yoshida T: Screening ultrasonography is useful for the diagnosis of
gastric and colorectal cancer. Hepatogastroenterology. 60:517–521.
2013.PubMed/NCBI
|
|
8
|
Shirahama M, Koga T, Ishibashi H, Uchida S
and Ohta Y: Sonographic features of colon carcinoma seen with
high-frequency transabdominal ultrasound. J Clin Ultrasound.
22:359–365. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piscaglia F, Nolsøe C, Dietrich CF,
Cosgrove DO, Gilja OH, Nielsen M Bachmann, Albrecht T, Barozzi L,
Bertolotto M, Catalano O, et al: The EFSUMB guidelines and
recommendations on the clinical practice of contrast enhanced
ultrasound (CEUS): Update 2011 on non-hepatic applications.
Ultraschall Med. 33:33–59. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Claudon M, Dietrich CF, Choi BI, Cosgrove
DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC,
et al: World Federation for Ultrasound in Medicine; European
Federation of Societies for Ultrasound; Guidelines and good
clinical practice recommendations for contrast enhanced ultrasound
(CEUS) in the liver-update 2012: A WFUMB-EFSUMB initiative in
cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and
ICUS. Ultraschall Med. 34:11–29. 2013.PubMed/NCBI
|
|
11
|
Esteban JM, Mollá MA, Tomás C and
Maldonado L: Improved detection of liver metastases with
contrast-enhanced wideband harmonic imaging: Comparison with CT
findings. Eur J Ultrasound. 15:119–126. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ueno N, Kawamura H, Hoshino T, Kadowaki A
and Nakamura K: Detection of alimentary tract hemorrhage on
contrast-enhanced ultrasonography. J Ultrasound Med. 25:683–686.
2006.PubMed/NCBI
|
|
13
|
Marelli C: Preliminary clinical experience
in cardiology with sonazoid. Am J Cardiol. 86:10G–13G. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kudo M, Matsui O, Izumi N, Iijima H,
Kadoya M and Imai Y: Liver Cancer Study Group of Japan:
Surveillance and diagnostic algorithm for hepatocellular carcinoma
proposed by the Liver Cancer Study Group of Japan: 2014 update.
Oncology. 87:(Suppl 1). S7–S21. 2014. View Article : Google Scholar
|
|
15
|
Ikeda K, Osaki Y, Nakanishi H, Nasu A,
Kawamura Y, Jyoko K, Sano T, Sunagozaka H, Uchino K, Minami Y, et
al: Recent progress in radiofrequency ablation therapy for
hepatocellular carcinoma. Oncology. 87:(Suppl 1). S73–S77. 2014.
View Article : Google Scholar
|
|
16
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, Gatter KC, Trarbach T, Folprecht G, Shi MM, Lebwohl D, Jalava T,
Laurent D, et al: Tumour and Angiogenesis Research Group: Vascular
density analysis in colorectal cancer patients treated with
vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials. Br J
Cancer. 107:1044–1050. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Truong M, Atri M, Bret PM, Reinhold C,
Kintzen G, Thibodeau M, Aldis AE and Chang Y: Sonographic
appearance of benign and malignant conditions of the colon. AJR Am
J Roentgenol. 170:1451–1455. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O'Malley ME and Wilson SR: US of
gastrointestinal tract abnormalities with CT correlation.
Radiographics. 23:59–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sullivan HC, Edgar MA, Cohen C, Kovach CK,
HooKim K and Reid MD: The utility of ERG, CD31 and CD34 in the
cytological diagnosis of angiosarcoma: An analysis of 25 cases. J
Clin Pathol. 68:44–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kishina M, Koda M, Tokunaga S, Miyoshi K,
Fujise Y, Kato J, Matono T, Sugihara T and Murawaki Y: Usefulness
of contrast-enhanced ultrasound with Sonazoid for evaluating liver
abscess in comparison with conventional B-mode ultrasound. Hepatol
Res. 45:337–342. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hiraoka A, Kume M, Miyagawa M, Tazuya N,
Ichiryu M, Ochi H, Tanabe A, Nakahara H, Shinbata Y, Kan M, et al:
Diagnostic value of sonazoid for hepatic metastasis: Comparison
with FDG PET/CT. Hepatogastroenterology. 57:1237–1240.
2010.PubMed/NCBI
|
|
22
|
Girlich C, Schacherer D, Jung EM, Klebl F
and Huber E: Comparison between quantitative assessment of bowel
wall vascularization by contrast-enhanced ultrasound and results of
histopathological scoring in ulcerative colitis. Int J Colorectal
Dis. 27:193–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pysz MA, Foygel K, Panje CM, Needles A,
Tian L and Willmann JK: Assessment and monitoring tumor vascularity
with contrast-enhanced ultrasound maximum intensity persistence
imaging. Invest Radiol. 46:187–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Onji K, Yoshida S, Tanaka S, Takemura Y,
Oka S, Yoshihara M, Yamada H, Okajima M and Chayama K:
Microvascular structure and perfusion imaging of colon cancer by
means of contrast-enhanced ultrasonography. Abdom Imaging.
37:297–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Yao X, Ge J, Hu F and Zhao Y: Can
vascular endothelial growth factor and microvessel density be used
as prognostic biomarkers for colorectal cancer? A systematic review
and meta-analysis. Scientific World Journal.
2014:1027362014.PubMed/NCBI
|
|
26
|
Sun H, Xu Y, Yang Q and Wang W: Assessment
of tumor grade and angiogenesis in colorectal cancer: Whole-volume
perfusion CT. Acad Radiol. 21:750–757. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Li L, Wang YX, Cui NY, Zou SM,
Zhou CW and Jiang YX: Time-intensity curve parameters in rectal
cancer measured using endorectal ultrasonography with sterile
coupling gels filling the rectum: Correlations with tumor
angiogenesis and clinicopathological features. Biomed Res Int.
2014:5878062014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsuzawa F, Einama T, Abe H, Suzuki T,
Hamaguchi J, Kaga T, Sato M, Oomura M, Takata Y, Fujibe A, et al:
Accurate diagnosis of axillary lymph node metastasis using
contrast-enhanced ultrasonography with Sonazoid. Mol Clin Oncol.
3:299–302. 2015.PubMed/NCBI
|
|
29
|
Miyamoto Y, Ito T, Takada E, Omoto K,
Hirai T and Moriyasu F: Efficacy of sonazoid (perflubutane) for
contrast-enhanced ultrasound in the differentiation of focal breast
lesions: Phase 3 multicenter clinical trial. AJR Am J Roentgenol.
202:W400–W407. 2014. View Article : Google Scholar : PubMed/NCBI
|
